Graham Capital Management, L.P. Ionis Pharmaceuticals Inc Transaction History

Graham Capital Management, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$42.03 - $53.55 $757,212 - $964,756	18,016 Added 143.84%	30,541 $1.32 Million
Q4 2023 Feb 14, 2024	SELL	$43.39 - $51.63 $85,174 - $101,349	-1,963 Reduced 13.55%	12,525 $633,000
Q3 2023 Nov 22, 2023	BUY	$38.5 - $47.13 $557,788 - $682,819	14,488 New	14,488 $657,000
Q3 2022 Nov 14, 2022	SELL	$36.54 - $48.66 $266,595 - $355,023	-7,296 Reduced 11.96%	53,717 $2.38 Million
Q2 2022 Aug 15, 2022	BUY	$31.71 - $43.0 $1.3 Million - $1.76 Million	40,913 Added 203.55%	61,013 $2.26 Million
Q1 2022 May 16, 2022	BUY	$29.88 - $37.04 $397,284 - $492,483	13,296 Added 195.41%	20,100 $744,000
Q4 2021 Feb 14, 2022	BUY	$25.61 - $35.1 $174,250 - $238,820	6,804 New	6,804 $207,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.